Pfizer (NYSE: PFE) has signed an agreement with the White House to help Americans access lower prescription drug prices and enhance U.S. biopharmaceutical innovation through a new website, “TrumpRx,” which connects patients to discounted drugs. President Trump and Pfizer CEO Albert Bourla emphasized the importance of this deal in addressing the financial burdens on American consumers who fund global research and development.
Loading PerspectiveSplit analysis...
